Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation

Ann Neurol. 2005 Jun;57(6):933-4. doi: 10.1002/ana.20510.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Female
  • Humans
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Male
  • Middle Aged
  • North America
  • Parkinson Disease / genetics*
  • Point Mutation*
  • Protein Serine-Threonine Kinases / genetics*

Substances

  • LRRK2 protein, human
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Protein Serine-Threonine Kinases